• Magazine
    • Past Issues
    • Subscribe
    • Change Mailing Address
    • Surveys
    • Guidelines for Authors
    • Editorial Calendar
    • Editorial Deadlines
  • Practice
    • Business Tips
    • Chiropractic Schools
    • Clinical & Technique
    • eBooks
    • eCourses
    • Infographics
    • Quizzes
    • Wellness & Nutrition
    • Personal Growth
    • Podcast
  • Resource Centers
  • Products & Services
    • Buyer’s Guide
    • Products Directory
    • Submit a Product
    • Vendor Login
  • Datebook
    • Become an Events Poster
    • Post an Event
    • View Events
  • Jobs
    • Jobs
    • Post a Job
  • Advertise
    • Advertising Information
    • Media Kit
    • Contact Us
    • Upload Advertising

Your Online Chiropractic Community

Chiropractic Economics Your Online Chiropractic Community
Subscribe
  • Home
  • Current Issue
  • News
  • Webinars
  • Chiropractic Research
  • Students
  • Coronavirus (COVID-19)

FDA warns epidural injections of corticosteroids for back and neck pain may cause severe neurological effects

Chiropractic Economics May 1, 2014

IntegrityLifeApril 30, 2014 — The U.S. Food and Drug Administration (FDA) recently issued a severe warning against the use of epidural corticosteroid injections for pain. The warning cautions “…that injection of corticosteroids into the epidural space of the spine may result in rare but serious adverse events, including loss of vision, stroke, paralysis, and death.”

Epidural injections to treat neck pain, back pain and radiating pain in the arms and legs are commonly used and have been in widespread use for decades. However, the effectiveness and safety of epidural injections of corticosteroids, such as hydrocortisone and methylprednisolone, have not been established. As a result, the FDA is requiring the addition of a warning to the drug labels of injectable corticosteroids to describe the risks associated with the off label use. It is estimated that approximately 9 million epidural injections are administered annually in the U.S. Other major industrialized nations have already placed highly restrictive limits and safeguards on the use of steroid injections.

“This is exactly why Integrity Life Sciences is determined to communicate the effectiveness of its non-surgical spinal decompression systems,” said James Gibson, president and CEO of Integrity Life Sciences, when asked about non-invasive treatment alternatives for back and neck pain.

“The recent FDA actions highlight the harsh reality that invasive and traditional pharmaceutical treatment of chronic neck and low back pain are not without risk,” he continued. “Due to the potential high risk and limited long term benefits associated with the treatment, a growing trend of doctors in pain management and obstetrics refuse to prescribe epidural injections. The underlying message from the FDA is clear that the effectiveness of steroid injections has not been established and that the treatment of back and neck pain is an evolving science.”

The FDA is formulating a Scientific Committee in the fall of 2014 to further address the risk versus reward of the controversial treatment of low back pain. Integrity Life Sciences is advocating for a seat at the panel when it is convened. A focus of the panel should be the constructive treatment therapy options utilizing Integrity’s non-surgical spinal decompression systems (ISCS). The ISCS with zero reported adverse events and an industry body of literature that establishes its effectiveness should be documented as a viable and safe treatment option and the stigmatization of questionable reimbursement defined.

The FDA warning may be viewed at: http://www.fda.gov/safety/medwatch/safetyinformation/safetyalertsforhumanmedicalproducts/ucm394530.htm.

Source: Integrity Life Sciences

Related Posts

  • AlignMed receives FDA RegistrationAlignMed receives FDA Registration
  • Learning the basics of low level laser therapyLearning the basics of low level laser therapy
  • FDA e-news recognizes Axiom case studyFDA e-news recognizes Axiom case study
  • Bipartisan legislation proposed for national CBD useBipartisan legislation proposed for national CBD use
  • Sciatica, lumbar disc herniation surgery vs. chiropracticSciatica, lumbar disc herniation surgery vs. chiropractic
  • How topical analgesics provide a safer pain relief optionHow topical analgesics provide a safer pain relief option

Filed Under: Industry News, News

Current Issue

Follow Us

  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • YouTube logoYouTube logoYouTube

820 A1A N Highway W18,

Ponte Vedra Beach, FL 32082

Phone 904.285.6020

Fax 904.395.9118

CONTACT US »

Privacy Policy & Terms of Service

Copyright © 2021, All Rights Reserved

SUBSCRIBE TO THE MAGAZINE

Get Chiropractic Economics magazine
delivered to your home or office. Just
fill out our form to request your FREE
subscription for 20 issues a year,
including two annual Buyers Guides.

SUBSCRIBE NOW »

Latest Chiropractic News

  • Upcoming April chiropractic workshops/conferences
  • Parker University announces technology partnerships for cutting-edge touch tables, software
  • Chiropractor wrestler attempts Olympic qualification, starts fundraising campaign
x